Focusing on Advances in Orthopedics: Xianshi Pharmaceutical Presents Core Products at Yunnan Provincial Orthopedic Academic Conference
Release date:
2025-11-06
KUNMING, Nov 06, 2025 — The 11th Yunnan Medical Association Orthopedics Academic Conference (3rd Session) recently concluded at Kunming Yun’an Convention Center. Organized by the Orthopedics Branch of Yunnan Medical Association and co-hosted by top local hospitals, the event gathered leading orthopedic experts and frontline clinicians to share cutting-edge surgical technologies, innovative diagnosis and treatment plans, and the latest industry development trends.
As an enterprise with professional layout in orthopedic pharmaceutical sectors, Hunan Xianshi Pharmaceutical Co., Ltd. was invited to participate in the exhibition and displayed three core orthopedic products, which drew extensive attention from participating specialists.
Three Star Products Attract Extensive Attention
The exhibited portfolio includes three flagship items
- Gudeli® Vitamin D3 Injection: guideline-recommended agent for vitamin D deficiency treatment
- Gudeli® Glucosamine Sulfate: nutritional supplement for articular cartilage
- Fizhitong Rivaroxaban Granules: preferred option for antithrombotic treatment
Gudeli® Vitamin D3 Injection stood out as the highlight of on-site communication due to its proven clinical merits. Clinicians held in-depth discussions comparing its efficacy against common oral vitamin D agents and vitamin D2 injection, covering applicable crowds and clinical value, which reflected strong clinical demand for optimized treatment schemes.
Gudeli® Vitamin D3 Injection: Precision Therapy Beyond Basic Nutrient Supplement
A key clinical point often overlooked is the essential difference between Vitamin D3 and Vitamin D2 in source, molecular structure and bioavailability, leading to obvious gaps in clinical efficacy and safety.
Superior to oral alternatives in absorption speed and therapeutic effect, Gudeli® Vitamin D3 Injection is recommended for three major clinical populations:
1. Patients with malabsorption issues
Including strict vegetarians, patients on parenteral nutrition, and those suffering from pancreatic dysfunction, hepatobiliary diseases, small intestinal lesions or gastrectomy sequelae, who cannot absorb oral vitamin D effectively via digestive tracts.
2. Children with rickets
For kids with poor medication compliance or diarrhea-related malabsorption, high-dose injectable treatment rapidly raises blood vitamin D concentration, controls illness progress and avoids skeletal malformation.
3. Postoperative patients
It rapidly relieves tetany caused by insufficient vitamin D after thyroidectomy or idiopathic tetany to accelerate rehabilitation.
Deep Clinical Collaboration to Innovate Orthopedic Treatment
The academic conference acts as an exchange platform linking pharmaceutical manufacturers and clinical practitioners. Through on-site communication, Xianshi Pharmaceutical conveyed product clinical value and collected first-hand practical demands from frontline medical staff.
In the future, the company will keep cooperating with hospitals and academic experts to promote standardized clinical medication of orthopedic drugs, improve local treatment levels, and provide high-quality pharmaceutical products and services for the development of orthopedic medicine.
Latest News
Share to
Hotline
Address
No. 19, Baizhu Road, Economic and Technological Development Zone, Liuyang City, Changsha, Hunan, China
Copyright © HUNAN XIANSHI PHARMACEUTICAL CO., LTD.
This site supports IPv4 IPv6 .